- Home
- WST vs VTR Comparison
WST vs VTR Comparison
Compare WST & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- VTR
- Stock Information
- Founded
- WST 1923
- VTR 1983
- Country
- WST United States
- VTR United States
- Employees
- WST N/A
- VTR N/A
- Industry
- WST Medical/Dental Instruments
- VTR Real Estate Investment Trusts
- Sector
- WST Health Care
- VTR Real Estate
- Exchange
- WST Nasdaq
- VTR Nasdaq
- Market Cap
- WST 23.2B
- VTR 25.3B
- IPO Year
- WST N/A
- VTR 1998
- Fundamental
- Price
- WST $332.77
- VTR $59.27
- Analyst Decision
- WST Strong Buy
- VTR Buy
- Analyst Count
- WST 5
- VTR 11
- Target Price
- WST $437.75
- VTR $62.00
- AVG Volume (30 Days)
- WST 494.1K
- VTR 3.1M
- Earning Date
- WST 02-13-2025
- VTR 02-12-2025
- Dividend Yield
- WST 0.25%
- VTR 3.04%
- EPS Growth
- WST N/A
- VTR N/A
- EPS
- WST 6.74
- VTR N/A
- Revenue
- WST $2,876,400,000.00
- VTR $4,797,115,000.00
- Revenue This Year
- WST N/A
- VTR N/A
- Revenue Next Year
- WST $6.08
- VTR $8.23
- P/E Ratio
- WST $49.37
- VTR N/A
- Revenue Growth
- WST N/A
- VTR 10.05
- 52 Week Low
- WST $265.00
- VTR $41.45
- 52 Week High
- WST $413.70
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- WST 58.00
- VTR 37.86
- Support Level
- WST $325.33
- VTR $57.62
- Resistance Level
- WST $335.53
- VTR $60.73
- Average True Range (ATR)
- WST 7.96
- VTR 1.18
- MACD
- WST 0.32
- VTR -0.14
- Stochastic Oscillator
- WST 78.28
- VTR 35.33
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.